KRYS Krystal Biotech Inc

Krystal Biotech Inc is a biopharmaceutical company. It uses gene therapy treatments for patients suffering from rare debilitating disorders.

$61.37  -1.34 (-2.14%)
As of 05/13/2021 12:14:44 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  09/20/2017
Outstanding shares:  22,203,807
Average volume:  92,863
Market cap:   $1,463,008,843
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    501147102
ISIN:        US5011471027
Sedol:      BD6JX35
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   5.47
PS ratio:   0.00
Return on equity:   -11.01%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy